5-[1-(3-chlorophenyl)-2,4,5-trimethylpyrrol-3-yl]-1-[(4-methoxyphenyl)methyl]-4-pyridin-2-ylimidazolidine-2-thione
C29H29ClN4OS — CID 133181199
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[1-(3-chlorophenyl)-2,4,5-trimethylpyrrol-3-yl]-1-[(4-methoxyphenyl)methyl]-4-pyridin-2-ylimidazolidine-2-thione
5-[1-(3-chlorophenyl)-2,4,5-trimethylpyrrol-3-yl]-1-[(4-methoxyphenyl)methyl]-4-pyridin-2-ylimidazolidine-2-thione (PubChem CID 133181199) has the molecular formula C29H29ClN4OS and a molecular weight of 517.10 g/mol. Its IUPAC name is 5-[1-(3-chlorophenyl)-2,4,5-trimethylpyrrol-3-yl]-1-[(4-methoxyphenyl)methyl]-4-pyridin-2-ylimidazolidine-2-thione.
Molecular Properties
| Compound Name | 5-[1-(3-chlorophenyl)-2,4,5-trimethylpyrrol-3-yl]-1-[(4-methoxyphenyl)methyl]-4-pyridin-2-ylimidazolidine-2-thione |
|---|---|
| PubChem CID | 133181199 |
| Molecular Formula | C29H29ClN4OS |
| Molecular Weight | 517.10 g/mol |
| Exact Mass | 516.18 |
| IUPAC Name | 5-[1-(3-chlorophenyl)-2,4,5-trimethylpyrrol-3-yl]-1-[(4-methoxyphenyl)methyl]-4-pyridin-2-ylimidazolidine-2-thione |
| SMILES | COc1ccc(CN2C(=S)NC(c3ccccn3)C2c2c(C)c(C)n(-c3cccc(Cl)c3)c2C)cc1 |
| InChI | InChI=1S/C29H29ClN4OS/c1-18-19(2)34(23-9-7-8-22(30)16-23)20(3)26(18)28-27(25-10-5-6-15-31-25)32-29(36)33(28)17-21-11-13-24(35-4)14-12-21/h5-16,27-28H,17H2,1-4H3,(H,32,36) |
| InChIKey | UAOFRZPJOLCKDW-UHFFFAOYSA-N |
| XLogP | 6.63 |
| TPSA | 42.32 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 517.10 |
| LogP ≤ 5 | 6.63 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 133181199 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.